Dublin, Sept. 12, 2023 (GLOBE NEWSWIRE) -- The "Global Specialty Pharmaceuticals Market by Type, Product, Distribution Channel - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Forecast 2023-2030" report has been added to ResearchAndMarkets.com's offering.
The Global Specialty Pharmaceuticals Market size was estimated at USD 66.24 billion in 2022, USD 92.50 billion in 2023, growing at a CAGR of 39.78% to reach USD 965.54 billion by 2030.
In this report, 2018 to 2021 are considered as historical years, 2022 is the base year, 2023 is the estimated year, and years from 2024 to 2030 are considered as forecast period.
The report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.
The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share.
The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.
The report provides insights on the following pointers:
- Market Penetration: Provides comprehensive information on the market offered by the key players
- Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
- Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
- Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
- Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
- Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
Market Segmentation & Coverage:
This research report categorizes the Global Specialty Pharmaceuticals Market in order to forecast the revenues and analyze trends in each of following sub-markets:
- Based on Type, the market is studied across CNS, Infectious Diseases, Oncology, Respiratory, and Women's Health. The Oncology is projected to witness significant market share during forecast period.
- Based on Product, the market is studied across Oral Pharmaceuticals, Parenteral Pharmaceuticals, and Transdermal Pharmaceuticals. The Parenteral Pharmaceuticals is projected to witness significant market share during forecast period.
- Based on Distribution Channel, the market is studied across Hospitals & Care Providers, Online Mode, Retail Pharmacies, and Specialty Pharmacies. The Online Mode is projected to witness significant market share during forecast period.
- The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.
The report answers questions such as:
- What is the market size and forecast of the Global Specialty Pharmaceuticals Market?
- What are the inhibiting factors and impact of COVID-19 shaping the Global Specialty Pharmaceuticals Market during the forecast period?
- Which are the products/segments/applications/areas to invest in over the forecast period in the Global Specialty Pharmaceuticals Market?
- What is the competitive strategic window for opportunities in the Global Specialty Pharmaceuticals Market?
- What are the technology trends and regulatory frameworks in the Global Specialty Pharmaceuticals Market?
- What is the market share of the leading vendors in the Global Specialty Pharmaceuticals Market?
- What modes and strategic moves are considered suitable for entering the Global Specialty Pharmaceuticals Market?
Market Dynamics
Drivers
- Increasing demand for specialty drugs to treat complex or serious chronic conditions
- Increased reimbursement through the medical benefit, and pharmacy benefit
- Attractive prospects for pharmaceutical companies from both business and medical innovation perspective
Restraints
- Cost sharing discourages the use leading to adverse health outcomes
Opportunities
- Vendors offering compliance programs, reimbursement assistance programs and distribution channels
- Growth of enhanced information technologies in the specialty pharmaceuticals sector
Challenges
- Less focus on the development of low-cost generic equivalents of specialty drugs
Competitive Portfolio
- AbbVie Inc.
- Amgen Inc.
- Bristol Myers Squibb Company
- Endo International PLC
- F. Hoffmann-La Roche Ltd.
- Gilead Sciences, Inc.
- Hyphens Pharma International Limited
- Merck KGaA
- Novartis AG
- Pfizer Inc.
- Sanofi S.A.
- Teva Pharmaceutical Industries Ltd.
- UnitedHealth Group
- Viatris Inc.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 180 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value (USD) in 2023 | $92.5 Billion |
| Forecasted Market Value (USD) by 2030 | $965.54 Billion |
| Compound Annual Growth Rate | 39.7% |
| Regions Covered | Global |
For more information about this report visit https://www.researchandmarkets.com/r/8xvg7j
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
